Accelerate Diagnostics In... (AXDX)
Accelerate Diagnostics Statistics
Share Statistics
Accelerate Diagnostics has 25.21M shares outstanding. The number of shares has increased by 14.33% in one year.
| Shares Outstanding | 25.21M |
| Shares Change (YoY) | 14.33% |
| Shares Change (QoQ) | 0.67% |
| Owned by Institutions (%) | 1.31% |
| Shares Floating | 15.31M |
| Failed to Deliver (FTD) Shares | 120 |
| FTD / Avg. Volume | 0.3% |
Short Selling Information
The latest short interest is 292.81K, so 1.17% of the outstanding shares have been sold short.
| Short Interest | 292.81K |
| Short % of Shares Out | 1.17% |
| Short % of Float | 1.74% |
| Short Ratio (days to cover) | 4.26 |
Valuation Ratios
The PE ratio is -0.56 and the forward PE ratio is -1.44. Accelerate Diagnostics's PEG ratio is 0.01.
| PE Ratio | -0.56 |
| Forward PE | -1.44 |
| PS Ratio | 2.39 |
| Forward PS | 0.6 |
| PB Ratio | -0.5 |
| P/FCF Ratio | -1.13 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Accelerate Diagnostics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of -1.19.
| Current Ratio | 0.71 |
| Quick Ratio | 0.62 |
| Debt / Equity | -1.19 |
| Debt / EBITDA | -1.98 |
| Debt / FCF | -2.7 |
| Interest Coverage | -2.69 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $109.33K |
| Profits Per Employee | $-467.71K |
| Employee Count | 107 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 3.15 |
Taxes
| Income Tax | -66K |
| Effective Tax Rate | 0.13% |
Stock Price Statistics
The stock price has increased by -45.85% in the last 52 weeks. The beta is 0.46, so Accelerate Diagnostics's price volatility has been higher than the market average.
| Beta | 0.46 |
| 52-Week Price Change | -45.85% |
| 50-Day Moving Average | 0.85 |
| 200-Day Moving Average | 1.35 |
| Relative Strength Index (RSI) | 26.72 |
| Average Volume (20 Days) | 39.53K |
Income Statement
In the last 12 months, Accelerate Diagnostics had revenue of 11.7M and earned -50.05M in profits. Earnings per share was -2.15.
| Revenue | 11.7M |
| Gross Profit | 2.7M |
| Operating Income | -35.31M |
| Net Income | -50.05M |
| EBITDA | -33.57M |
| EBIT | -36.99M |
| Earnings Per Share (EPS) | -2.15 |
Balance Sheet
The company has 15.1M in cash and 66.58M in debt, giving a net cash position of -51.48M.
| Cash & Cash Equivalents | 15.1M |
| Total Debt | 66.58M |
| Net Cash | -51.48M |
| Retained Earnings | 0 |
| Total Assets | 28.56M |
| Working Capital | -8.96M |
Cash Flow
In the last 12 months, operating cash flow was -24.19M and capital expenditures 0, giving a free cash flow of -24.7M.
| Operating Cash Flow | -24.19M |
| Capital Expenditures | 0 |
| Free Cash Flow | -24.7M |
| FCF Per Share | -1.06 |
Margins
Gross margin is 23.12%, with operating and profit margins of -301.85% and -427.81%.
| Gross Margin | 23.12% |
| Operating Margin | -301.85% |
| Pretax Margin | -428.37% |
| Profit Margin | -427.81% |
| EBITDA Margin | -287% |
| EBIT Margin | -301.85% |
| FCF Margin | -211.17% |
Dividends & Yields
AXDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for AXDX is $1, which is 96.1% higher than the current price. The consensus rating is "Hold".
| Price Target | $1 |
| Price Target Difference | 96.1% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 12, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Jul 12, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -4.14 |
| Piotroski F-Score | 2 |